GLUE NASDAQ
Credit Risk of going bust: higher than 56% of companies Debt: 4.0% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.08 (down 99.3%), Monte Rosa Therapeutics, Inc. would be worth roughly what it owes.
Total debt $38.0M against a stock market value of $909.4M.
Distance to default 4.57 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $21.3M (short-term plus half of long-term), stock volatility 78.8%; Altman Z'' 3.56. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Boston, MA 02118
US
Monte Rosa Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering novel, small-molecule precision medicines. Their core approach involves leveraging the body's inherent mechanisms to precisely eliminate therapeutically relevant proteins. Among their key initiatives is an oral molecular glue degrader designed to target GSPT1, a specific translational termination factor and degron-containing protein, with the aim of treating Myc-driven cancers. The company's pipeline further includes programs for CDK2 in ovarian, uterine, and breast cancers, alongside NEK7 for addressing a spectrum of inflammatory conditions such as Crohn's disease, neurodegenerative ailments, diabetes, and liver disease. Moreover, VAV1 is being explored as a target for autoimmune disorders, and BCL11A, a protein holding significant therapeutic relevance, is under investigation for hemoglobinopathies. Founded in 2019, Monte Rosa Therapeutics, Inc. operates from its headquarters in Boston, Massachusetts.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Bowen Matthew | S-Sale | 13 | $10.56 | 2026-10-05 |
| Warmuth Markus | S-Sale | 9,500 | $23.18 | 2026-07-16 |
| Champoux Jennifer | S-Sale | 4,351 | $23.38 | 2026-07-15 |
| Townson Sharon | M-Exempt | 6,000 | $6.14 | 2026-07-06 |
| Townson Sharon | S-Sale | 5,600 | $23.25 | 2026-07-06 |